IONS vs OTIS · rev $514.0M vs P/E 19, rev $7.42B
Ionis Pharmaceuticals Inc (IONS) versus Otis Worldwide Corp (OTIS) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Otis Worldwide Corp (OTIS) is a specialty industrial machinery company listed on NYSE.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported OTIS revenue for 2026-06-30 was $7.42B. Net income was $768.0M. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
IONS currently screens at market cap $12.28B. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
Not investment advice. Open the IONS and OTIS stock pages for the full models.
Not investment advice.